The Selleck ATM/ATR inhibitor qualitative studies also lacked depth in the data that were collected, represented,
and interpreted, leaving further interpretation and synthesis of the findings difficult. Despite this, the main outcome of agitation was measured by the CMAI in all studies reporting on that outcome, and this tool is known to be a valid and reliable measure.38 Dementia research, in general, may benefit from an agreed set of tools to measure common mood and behavior-related outcomes and agreed ways in which to measure more physical/physiological outcomes, such as sleep, physical activity, and falls. Future research also may need to consider what outcomes are the most relevant to measure and how they should be measured and interpreted across studies. In particular, in the evidence synthesized here there was a lack of quality-of-life outcomes and a lack of consistency in the recording of medication use and occurrence of falls. The measurement of quality-of-life issues in people with dementia is a complex issue, but recently a measure based on the standardized European Quality Of Life (EUROQOL) tool39
NVP-BGJ398 chemical structure has been designed specifically for measuring Dementia-related Quality Of Life (DEMQOL),40 which may assist future research in this area. From the evidence collected in this review, it is not clear how much of an impact the different residential environments may have had on the outcomes. However, what is clear is the concern and interest around this area, and the necessity for higher-quality research to understand the mechanisms behind interventions and evaluate them.10 and 11
There may be important features about the interactions between staff and residents, and the residents themselves, as well as with the physical environment in specialized dementia units in comparison with homes with a mix of elderly people with and without dementia. Equally, the features of the garden (eg, a general yard versus a landscaped garden versus a dementia-specific garden) also may have an impact on the level of benefit residents with dementia may gain. There is a glut of literature that has looked at the design of gardens specialized for the elderly and for Olopatadine those with dementia41 but the recommendations appear as yet to be unused in the research literature. All these aspects will be important to consider in future research for them to be explored in future syntheses. The measurement of medication usage or prescribing often was not recorded in these studies, but consistent reporting of this across studies would help us to understand if the effectiveness of the garden in residents’ mood and behavior is also reflected in the use of medications for those residents.